Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
journalStr:"ClinicalTrials.gov"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=9
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=9
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields&page=9
PubPharm (6.524)
81
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma : A Randomized Phase 2 Trial of Brentuximab Vedotin (SGN35, NSC# 749710), or Crizotinib (NSC#749005, Commercially Labeled) in Combination With Chemotherapy for Newly Diagnosed Patients With Anaplastic Large Cell Lymphoma (ALCL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
82
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab : Phase II Study of Daratumumab in Combination With Azacitidine and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients Previously Treated With Daratumumab
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
83
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis : OPEN-LABEL INDUCTION AND MAINTENANCE STUDY OF ORAL CP-690,550 (TOFACITINIB) IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
84
AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS : AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
85
A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome : The NOR-CACTUS Trial - A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
86
Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome : Contribution of Magnetic Resonance Imaging in Immune Effector Cell-Associated Neurotoxicity Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
87
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma : A PHASE 1B, OPEN-LABEL STUDY OF ELRANATAMAB IN COMBINATION WITH CARFILZOMIB PLUS DEXAMETHASONE AND ELRANATAMAB IN COMBINATION WITH PF-07901801 IN PARTICIPANTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
88
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma : An Open-label, Randomized, Phase 3 Study of Linvoseltamab (REGN5458; Anti- BCMA x Anti-CD3 Bispecific Antibody) Versus the Combination of Elotuzumab, Pomalidomide, and Dexamethasone (EPd), in Patients With Relapsed/Refractory Multiple Myeloma (LINKER-MM3)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
89
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations : A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
90
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide) : A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[653]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Medienart
6.524
Aufsätze
6.524
E-Artikel
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
6.524
610
5.733
Study Type: Interventional
2.875
Recruitment Status: Completed
1.384
Recruitment Status: Recruiting
1.361
Phase: Phase 2
1.068
Phase: Phase 3
1.046
Phase: Phase 4
893
Multiple Myeloma
864
Neoplasms, Plasma Cell
736
Study Type: Observational
533
Asthma
524
Recruitment Status: Terminated
476
Recruitment Status: Active, not recruiting
466
Recruitment Status: Not yet recruiting
417
Recruitment Status: Unknown status
401
Phase: Phase 1
300
Medical Condition: Asthma
298
Medical Condition: Multiple Myeloma
269
Recruitment Status: Withdrawn
202
Pain, Postoperative
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
4.193
2020-
2.165
2010-2019
166
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
6.524
Englisch
Haven't found what you're looking for?
Wird geladen...